Recital 3, Regulation (EU) 2023/4

In forcesince 3 Jan 2023

On 21 February 2020, the company Monterey Mushrooms Inc (‘the applicant’) submitted an application for an authorisation to the Commission in accordance with Article 10(1) of Regulation (EU) 2015/2283 to place vitamin D2 mushroom powder on the Union market as a novel food. The applicant requested for vitamin D2 mushroom powder to be used in a number of foods intended for the general population. The applicant also requested the novel food to be used in food supplements for infants from 7 to 11 months of age, as well as in food supplements as defined in Directive 2002/46/EC of the European Parliament and of the Council [Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements (OJ L 183, 12.7.2002, p. 51).], excluding food supplements for infants and young children, foods for special medical purposes as defined in Regulation (EU) No 609/2013 of the European Parliament and of the Council [Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on food intended for infants and young children, food for special medical purposes, and total diet replacement for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the Council and Commission Regulations (EC) No 41/2009 and (EC) No 953/2009 (OJ L 181, 29.6.2013, p. 35).], excluding foods for special medical purposes intended for infants, and total diet replacement for weight control as defined in Regulation (EU) No 609/2013. During the application process, the applicant withdrew the request for authorisation of the novel food in food supplements for infants from 7 to 11 months of age.